Dehydrated form of plasmid expressing basic fibroblast growth factor-polyethylenimine complex is a novel and accurate method for gene transfer to the cornea

Current Eye Research

Volumn 30, Issue 11, 2005, Pages 1015-1024

  Kuo, Chien Neng ^a   Yang, Lin Cheng ^b   Wu, Pei Chang ^a   Kuo, Hsi Kung ^a   Kuo, Chian Jue ^c   Tai, Ming Hong ^d  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c TAIPEI CITY PSYCHIATRIC CENTER   (Taiwan)

^d KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Angiogenesis; Cornea; Fibroblast growth factor; Nonviral vector; Polyethylenimine

Indexed keywords

FIBROBLAST GROWTH FACTOR; GREEN FLUORESCENT PROTEIN; POLYETHYLENEIMINE;

ANALYTIC METHOD; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA; CORNEA NEOVASCULARIZATION; DOSE RESPONSE; ENVIRONMENTAL TEMPERATURE; EYE; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; IMMUNOCHEMISTRY; MALE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CAPILLARIES; CORNEA; DESICCATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; FIBROBLAST GROWTH FACTOR 2; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PLASMIDS; POLYETHYLENEIMINE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; TIME FACTORS;

EID: 31544456364     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680500330512     Document Type: Article

References (48)

1. Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest. 1999;103:1231-1236.
2. Chang JH, Gabison EE, Kato T, Azar DT. Corneal neovascularization. Curr Opin Ophthalmol. 2001;12:242-249.
3. Aviles RJ, Annex BH, Lederman RJ. Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF-2). Br J Pharmacol. 2003;140:637-646.
4. Soubrane G, et al. Binding of basic fibroblast growth factor to normal and neovascularized rabbit cornea. Invest Ophthalmol Vis Sci. 1990;31:323-333.
5. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M. Receptor specificity of the fibroblast growth factor family. J Biol Chem. 1996;271:15292-15297.
6. Akimoto M, et al. Adenovirally expressed basic fibroblast growth factor rescues photoreceptor cells in RCS rats. Invest Ophthalmol Vis Sci. 1999;40:273-279.
7. Nguyen TH, Murakami A, Fujiki K, Kanai A. Transferrin-polyethylenimine conjugate, FuGENE6 and TranslT-LT as nonviral vectors for gene transfer to the corneal endothelium. Jpn J Ophthalmol. 2002;46:140-146.
8. Molina MC, Allison SD, Anchordoquy TJ. Maintenance of nonviral vector particle size during the freezing step of the lyophilization process is insufficient for preservation of activity: insight from other structural indicators. J Pharm Sci. 2001;90:1445-1455.
9. Mahato RI. Nonviral peptide-based approaches to gene delivery. J Drug Target. 1999;7:249-268.
10. Shewring L, et al. A non-viral vector system for efficient gene transfer to corneal endothelial cells via membrane integrin. Transplantation. 1997;64:763-769.
11. Hudde T, et al. Activated polyamidoamine dendrimer as non-viral vector for gene transfer to the corneal endothelium. Gene Ther. 1999;6:939-943.
12. Gustafsson J, Arvidson G, Karlsson G, Almgren M. Complexes between cationic liposomes and DNA visualized by cryo-TEM. Biochim Biophys Acta. 1995;1235:305-312.
13. Anchordoquy TJ, Koe GS. Physical stability of nonviral plasmid-based therapeutics. J Pharm Sci. 2000;89:289-296.
14. Maa YF, et al. Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders. Pharm Res. 1998;15:768-775.
15. Seville PC, Kellaway IW, Birchall JC. Preparation of dry powder dispersions for non-viral gene delivery by freeze-drying and spray-drying. J Gene Med. 2002;4:428-437.
16. D'Amato RJ, Loughnan MS, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA. 1994;91:4082-4085.
17. Epstein RJ, Hendricks RL, Stulting RD. Interleukin-2 induces corneal neovascularization in A/J mice. Cornea. 1990;9:318-323.
18. Kenyon BM, et al. A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci. 1996;37:1625-1632.
19. Boletta A, Benigni A, Lutz J, Remuzzi G, Soria MR, Monaco L. Nonviral gene delivery to the rat kidney with polyethylenimine. Hum Gene Ther. 1997;8:1243-1251.
20. Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ. A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci. 1996;37:1625-1632.
21. Friesel R, Maciag T. Fibroblast growth factor prototype release and fibroblast growth factor signaling. Thromb Haemostas. 1999;82:748-754.
22. Dow JK, DeVere White RW. Fibroblast growth factor 2: its structure and properties, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions. Urology. 2000;55:800-806.
23. Chang LK, Garcia-Cardena G, Farnebo F, Fannon M, Chen EJ, Butterfield C, Moses MA, Mulligan RC, Folkman J, Kaipainen A. Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci USA. 2004;101:11658-11663.
24. Florkiewicz RZ, Sommer A. Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. Proc Natl Acad Sci USA. 1989;86:3978-3981.
25. Prats H, Kaghad M, Prats AC, Klagsbrun M, Lelias JM, Liauzun P, Chalon P, Tauber JP, Amalric F, Smith JA, et al. High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc Natl Acad Sci USA. 1989;86:1836-1840.
26. Arnaud E, Touriol C, Boutonnet C, Gensac MC, Vagner S, Prats H, Prats AC. A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor. Mol Cell Biol. 1999;19:505-514.
27. Delrieu I. The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): an insight into an intracrine mechanism [Review]. FEBS Lett. 2000;468:6-10.
28. Pasumarthi KB, Kardami E, Cattini PA. High and low molecular weight fibroblast growth factor-2 increase proliferation of neonatal rat cardiac myocytes but have differential effects on binucleation and nuclear morphology. Evidence for both paracrine and intracrine actions of fibroblast growth factor-2. Cire Res. 1996;78:126-136.
29. Grothe C, Meisinger C, Holzschuh J, Wewetzer K, Cattini P. Overexpression of the 18 kD and 21/23 kD fibroblast growth factor-2 isoforms in PC12 cells and Schwann cells results in altered cell morphology and growth. Brain Res Mol Brain Res. 1998;57:97-105.
30. Amalric F, Bouche G, Bonnet H, Brethenou P, Roman AM, Truchet I, Quarto N. Fibroblast growth factor-2 (FGF-2) in the nucleus: translocation process and targets. Biochem Pharmacol. 1994;47:111-115.
31. Muller-Ostermeyer F, Claus P, Grothe C. Distinctive effects of rat fibroblast growth factor-2 isoforms on PC12 and Schwann cells. Growth Factors. 2001;19:175-191.
32. Claus P, Doring F, Gringel S, Muller-Ostermeyer F, Fuhlrott J, Kraft T, Grothe C. Differential intranuclear localization of fibroblast growth factor-2 isoforms and specific interaction with the survival of motoneuron protein. J Biol Chem. 2003;278:479-485.
33. Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, Klagsbrun M. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA. 1987;84:2292-2296.
34. Kay EP, Gu X, Ninomiya Y, Smith RE. Corneal endothelial modulation: a factor released by leukocytes induces basic fibroblast growth factor that modulates cell shape and collagen. Invest Ophthalmol Vis Sci. 1993;34:663-672.
35. Renko M, Quarto N, Morimoto T, Rifkin DB. Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J Cell Physiol. 1990;144:108-114.
36. Bouche G, Gas N, Prats H, Baldin V, Tauber JP, Teissie J, Amalric F. Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing G0-G1 transition. Proc Natl Acad Sci USA. 1987;84:6770-6774.
37. Choi J, Ko MK, Kay EP. Subcellular localization of the expressed 18 kDa FGF-2 isoform in corneal endothelial cells. Mol Vis. 2000;6:222-231.
38. Chen YL, Israelachvili JN. Effects of ambient conditions on adsorbed surfactant and polymer monolayers. J Phys Chem. 1992;96:7752-7760.
39. Reese HR, Zimm BH. Fracture of polymer chains in extensional flow: experiments with DNA, and a molecular dynamics simulation. J Chem Phys. 1990;92:2650-2662.
40. Bloomfield VA. DNA condensation. Curr Opin Struct Biol. 1996;6:334-341.
41. Lobo BA, et al. Differential scanning calorimetric studies of the thermal stability of plasmid DNA complexed with cationic lipids and polymers. J Pharm Sci. 2002;91:454-466.
42. Kuo JH. The effect of protective agents on the stability of plasmid DNA by the process of spray-drying. J Pharm Pharmacol. 2003;55:301-306.
43. Kurisawa M, Yokoyama M, Okano T. Gene expression control by temperature with thermo-responsive polymeric gene carriers. J Controlled Release. 2000;69:127-137.
44. Cherng JY, et al. Effect of DNA topology on the transfection efficiency of poly ((2-dimethylamino) ethyl methacrylate)-plasmid complexes. J Controlled Release. 1999;60:343-353.
45. Hinrichs WL, Schuurmans-Nieuwenbroek NM, van de Wetering P, Hennink WE. Thermosensitive polymers as carriers for DNA delivery. J Controlled Release. 1999;60:249-259.
46. Gebhart CL, Kabanov AV. Evaluation of polyplexes as gene transfer agents. J Controlled Release. 2001;73:401 -416.
47. Boussif O, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA. 1995;92:7297-7301.
48. Kuo JH, Lo YL, Shau MD, Cherng JY. A thermodynamic study of cationic polymer-plasmid DNA complexes by highly sensitive differential scanning calorimetry. J Controlled Release. 2002;81:321-325.